Pre-diagnostic faecal calprotectin levels in patients with colorectal cancer: a retrospective study

[11] Sung JJ(2017)Cancer-associated fecal microbial markers in colorectal cancer detection Int J Cancer 141 2528-408

[12] Young GP(2001)Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma Gut 49 402-460

[13] Kuipers EJ(2002)Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease Gastroenterology 123 450-1240

[14] Morikawa T(2021)British Society of Gastroenterology guidelines on the management of irritable bowel syndrome Gut 70 1214-588

[15] Kato J(2008)Low-dose aspirin-induced gastrointestinal diseases: past, present, and future J Gastroenterol 43 581-344

[16] Yamaji Y(1996)Faecal calprotectin shedding after short-term treatment with non-steroidal anti-inflammatory drugs Scand J Gastroenterol 31 339-363

[17] Wada R(2017)Diagnostic accuracy of faecal biomarkers in detecting colorectal cancer and adenoma in symptomatic patients Aliment Pharmacol Ther 45 354-506

[18] Mitsushima T(2016)Faecal calprotectin in patients with suspected colorectal cancer: a diagnostic accuracy study Br J Gen Pract 66 e499-195

[19] Shiratori Y(2010)Diagnostic value of faecal calprotectin in unselected outpatients referred for colonoscopy: a multicenter prospective study Dig Liver Dis 42 191-1076

[20] Smith A(1993)Faecal calprotectin: a novel test for the diagnosis of colorectal cancer? Scand J Gastroenterol 28 1073-423

[11] Sung JJ(2017)Cancer-associated fecal microbial markers in colorectal cancer detection Int J Cancer 141 2528-408

[12] Young GP(2001)Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma Gut 49 402-460

[13] Kuipers EJ(2002)Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease Gastroenterology 123 450-1240

[14] Morikawa T(2021)British Society of Gastroenterology guidelines on the management of irritable bowel syndrome Gut 70 1214-588

[15] Kato J(2008)Low-dose aspirin-induced gastrointestinal diseases: past, present, and future J Gastroenterol 43 581-344

[16] Yamaji Y(1996)Faecal calprotectin shedding after short-term treatment with non-steroidal anti-inflammatory drugs Scand J Gastroenterol 31 339-363

[17] Wada R(2017)Diagnostic accuracy of faecal biomarkers in detecting colorectal cancer and adenoma in symptomatic patients Aliment Pharmacol Ther 45 354-506

[18] Mitsushima T(2016)Faecal calprotectin in patients with suspected colorectal cancer: a diagnostic accuracy study Br J Gen Pract 66 e499-195

[19] Shiratori Y(2010)Diagnostic value of faecal calprotectin in unselected outpatients referred for colonoscopy: a multicenter prospective study Dig Liver Dis 42 191-1076

[20] Smith A(1993)Faecal calprotectin: a novel test for the diagnosis of colorectal cancer? Scand J Gastroenterol 28 1073-423